Global COVID-19 Vaccines Market Opportunity Assessment and Forecast Report 2021-2026
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
This report gives a COVID-19 disease overview, epidemiology overview, current marketed vaccines, unmet needs, pipeline assessment, and market outlook.
The publisher forecasts three different potential scenarios for the future use of COVID-19 vaccines:
The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.
Scope
This report includes:
Executive Summary
Disease Overview: History of the outbreak, Etiology and Pathophysiology
Epidemiology
Current Vaccination Options: Includes detailed product profiles with SWOT analysis
Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
Market Outlook
Reasons to Buy
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Key Topics Covered:
1. Executive Summary
2. Disease Overview
3. Epidemiology
4. Current Vaccination Options
5. Unmet Needs and Opportunities
6. Pipeline Assessment
7. R&D Strategies
8. Market Outlook
9. Appendix
Companies Mentioned
Pfizer
BioNTech
Moderna
AstraZeneca
Johnson & Johnson
Novavax
CureVac
Sanofi
GlaxoSmithKline
Arcturus
Medicago
Valneva
Inovio
For more information about this report visit https://www.researchandmarkets.com/r/48oajz
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900